Lecturer in Clinical Biochemistry, University of Westminster
Dr David Gaze completed both Undergraduate and Postgraduate degrees in West Yorkshire followed by a PhD in Clinical Biochemistry in London, United Kingdom. He is currently lecturer in Clinical Biochemistry at the University of Westminster and Honorary Cardiac Research Scientist within the Department of Chemical Pathology, Clinical Blood Sciences at St George’s Hospital and Medical School, London.
Dr Gaze has authored and co-authored in excess of 150 peer reviewed papers and over 200 abstracts, as well as presented at over 50 internationally invited conferences. He has contributed six book chapters on Cardiovascular disease and biomarkers as well as writing a textbook on cardiac troponin. He is a peer reviewer of 25 medical journals.
Dr Gaze is a member of the Royal Society of Medicine of London; The Association for Clinical Biochemistry, of which he chairs the Clinical Sciences Review Committee for the Annals of Clinical Biochemistry. He is also a member of the American Association of Clinical Chemistry; Institute of Biomedical Sciences; Institute of Biology; European Society of Pathology; The Pathological Society of Great Britain and Ireland and associate member of the Royal Institution of London.
Dr Gaze and colleagues have won a number of awards including two distinguished Abstract awards from the National Academy of Clinical Biochemistry as well as Diploma for Oral Presentation regarding D-dimer, natriuretic peptide and cardiac troponin in dialysis patients presented at the 17th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine and the 60th National congress of the Netherlands Society of Clinical Chemistry and Laboratory Medicine in Amsterdam in 2007.
Dexamethasone: what is the breakthrough treatment for COVID-19?
Jun 21, 2020 11:24 am UTC| Health
Six months and eight million positive cases since the COVID-19 pandemic broke out in Wuhan, scientists have announced the first major breakthrough in the search for a drug to fight the disease. A research team at Oxford...
There’s an extra $1 billion on the table for NT schools. This could change lives if spent well
Political donations rules are finally in the spotlight – here’s what the government should do